Stock 000930 COFCO BIOTECHNOLOGY CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials COFCO Biotechnology Co., Ltd.

Equities

000930

CNE000000ZR7

Diversified Chemicals

End-of-day quote Shenzhen S.E.
Other stock markets
 06:00:00 2024-04-25 pm EDT 		5-day change 1st Jan Change
6.14 CNY +1.82% Intraday chart for COFCO Biotechnology Co., Ltd. +3.19% -7.53%
Apr. 24 COFCO Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Apr. 24 COFCO Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 13,710 12,194 15,710 20,280 15,594 12,382
Enterprise Value (EV) 1 20,751 15,795 21,879 22,558 17,799 14,542
P/E ratio 28.5 x 20.6 x 26.3 x 17.8 x 14.7 x -20.3 x
Yield 0.34% 0.24% 0.77% 2.25% 6.82% -
Capitalization / Revenue 0.77 x 0.63 x 0.79 x 0.86 x 0.78 x 0.61 x
EV / Revenue 1.17 x 0.81 x 1.1 x 0.96 x 0.89 x 0.71 x
EV / EBITDA 15.5 x 8.29 x 17.8 x 12.2 x 9.07 x 339 x
EV / FCF -8.03 x 22.9 x -4.96 x 7.75 x 95.1 x 11.4 x
FCF Yield -12.5% 4.37% -20.2% 12.9% 1.05% 8.75%
Price to Book 1.49 x 1.24 x 1.51 x 1.78 x 1.29 x 1.18 x
Nbr of stocks (in thousands) 1,847,644 1,847,644 1,865,764 1,865,718 1,865,274 1,864,721
Reference price 2 7.420 6.600 8.420 10.87 8.360 6.640
Announcement Date 4/29/19 4/27/20 4/28/21 4/28/22 4/26/23 4/24/24
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 17,704 19,472 19,909 23,469 19,918 20,379
EBITDA 1 1,337 1,906 1,231 1,842 1,962 42.89
EBIT 1 732.2 1,486 799.2 1,416 1,527 -419.7
Operating Margin 4.14% 7.63% 4.01% 6.03% 7.67% -2.06%
Earnings before Tax (EBT) 1 617.8 666.3 801.9 1,383 1,360 -542.5
Net income 1 483 592.8 593.1 1,133 1,059 -601.6
Net margin 2.73% 3.04% 2.98% 4.83% 5.32% -2.95%
EPS 2 0.2600 0.3209 0.3202 0.6109 0.5700 -0.3267
Free Cash Flow 1 -2,584 691 -4,415 2,910 187.1 1,273
FCF margin -14.59% 3.55% -22.18% 12.4% 0.94% 6.24%
FCF Conversion (EBITDA) - 36.25% - 157.99% 9.53% 2,967.08%
FCF Conversion (Net income) - 116.56% - 256.84% 17.67% -
Dividend per Share 2 0.0250 0.0160 0.0650 0.2450 0.5700 -
Announcement Date 4/29/19 4/27/20 4/28/21 4/28/22 4/26/23 4/24/24
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 7,042 3,601 6,169 2,278 2,206 2,160
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) 5.267 x 1.889 x 5.012 x 1.236 x 1.124 x 50.36 x
Free Cash Flow 1 -2,584 691 -4,415 2,910 187 1,273
ROE (net income / shareholders' equity) 6.63% 5.63% 5.98% 10% 8.74% -5.28%
ROA (Net income/ Total Assets) 2.18% 4.96% 2.65% 4.59% 5.28% -1.51%
Assets 1 22,124 11,954 22,348 24,680 20,054 39,777
Book Value Per Share 2 4.990 5.320 5.570 6.110 6.490 5.600
Cash Flow per Share 2 0.4200 0.3800 0.3500 0.6000 0.5500 0.7900
Capex 1 868 901 988 1,110 566 635
Capex / Sales 4.9% 4.63% 4.96% 4.73% 2.84% 3.11%
Announcement Date 4/29/19 4/27/20 4/28/21 4/28/22 4/26/23 4/24/24
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Annual profits - Rate of surprise

Company calendar

Sector Diversified Chemicals

1st Jan change Capi.
COFCO BIOTECHNOLOGY CO., LTD. Stock COFCO Biotechnology Co., Ltd.
-7.53% 1.58B
SHIN-ETSU CHEMICAL CO., LTD. Stock Shin-Etsu Chemical Co., Ltd.
-0.19% 74.89B
BASF SE Stock BASF SE
+0.09% 46.52B
DUPONT DE NEMOURS, INC. Stock DuPont de Nemours, Inc.
-4.19% 30.82B
PIDILITE INDUSTRIES LIMITED Stock Pidilite Industries Limited
+9.85% 18.19B
BRENNTAG SE Stock Brenntag SE
-10.05% 11.54B
EASTMAN CHEMICAL COMPANY Stock Eastman Chemical Company
+6.39% 11.24B
SYENSQO SA/NV Stock Syensqo SA/NV
-8.09% 9.73B
ASAHI KASEI CORPORATION Stock Asahi Kasei Corporation
+2.79% 9.4B
SRF LIMITED Stock SRF Limited
+6.35% 9.37B
Diversified Chemicals
  1. Stock Market
  2. Equities
  3. 000930 Stock
  4. Financials COFCO Biotechnology Co., Ltd.